WASHINGTON (AP) — U.S. regulators OK first new Alzheimer’s drug in nearly 20 years, against the advice of their own outside experts.
3 years ago Featured, National News, News
More Articles:
-
October 12
Poll: Knudsen leads Alke by 18% -
October 4
Sheehy, Tester Debate